SCHEMBL2034265

SCHEMBL2034265

C=C(C(=O)OCC)N1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
TSHR P16473 4/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 5/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
ATM Q13315 1/20 0.40
GAA P10253 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29109686 1.00 ALDH1A1 (0.41) ALDH1A1TSHRMAPTHPGDL3MBTL1
SCHEMBL21925345 0.98 ALDH1A1 (0.42) ALDH1A1TSHRMAPTHPGDL3MBTL1
SCHEMBL465145 0.90 ALDH1A1 (0.46) ALDH1A1TSHRMAPTSMN1; SMN2LMNA
SCHEMBL27777215 0.85 L3MBTL1 (0.41) ALDH1A1TSHRHPGDL3MBTL1SMN1; SMN2
SCHEMBL21925353 0.83 L3MBTL1 (0.39) ALDH1A1TSHRHPGDL3MBTL1SMN1; SMN2
SCHEMBL3134341 0.81 TSHR (0.62) ALDH1A1TSHRMAPTHPGDL3MBTL1
SCHEMBL29049790 0.81 MAPT (0.39) ALDH1A1TSHRMAPTSMN1; SMN2LMNA
SCHEMBL1819086 0.80 MAPT (0.61) ALDH1A1TSHRMAPTHPGDL3MBTL1
SCHEMBL28966044 0.78 DPP7 (0.36) ALDH1A1TSHRHPGDL3MBTL1NPC1
SCHEMBL6331933 0.78 MAPT (0.62) ALDH1A1TSHRMAPTHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021103178-A1 ORGANOSILICON FOAM WITH INTERPENETRATING NETWORK PH RESPONSIVENESS 广东省测试分析研究所(中国广州分析测试中心) 2021-06-03 WO claimed
CN-117143110-A Tumor permeation type carrier-free nano-drug and preparation method and application thereof 浙江大学 2023-12-01 CN disclosed
WO-2021103178-A1 ORGANOSILICON FOAM WITH INTERPENETRATING NETWORK PH RESPONSIVENESS 广东省测试分析研究所(中国广州分析测试中心) 2021-06-03 WO disclosed
CN-109337591-B Low-volatility ultraviolet-curing optical structure adhesive and preparation method thereof 东莞市派乐玛新材料技术开发有限公司 2021-03-30 CN disclosed
CN-110935199-B Organosilicon foam with interpenetrating network pH responsiveness 广东省测试分析研究所(中国广州分析测试中心) 2021-01-12 CN disclosed
EP-3004050-B1 CYANOSTILBENES ROLIC TECH AG (CH) 2020-09-02 EP disclosed
CN-110935199-A Organosilicon foam with interpenetrating network pH responsiveness 广东省测试分析研究所(中国广州分析测试中心) 2020-03-31 CN disclosed
US-10329486-B2 Cyanostilbenes ROLIC AG (CH) 2019-06-25 US disclosed
EP-3004050-A1 CYANOSTILBENES Rolic AG (CH) 2016-04-13 EP disclosed
US-20160083655-A1 CYANOSTILBENES ROLIC AG (CH) 2016-03-24 US disclosed
WO-2014191292-A1 CYANOSTILBENES ROLIC AG (CH) 2014-12-04 WO disclosed
US-7959990-B2 Adjustment of liquid crystals; oligomers, dendrimers, or polymer in solution is applied to support; crosslinking by radiation or polarized light ROLIC AG (CH) 2011-06-14 US disclosed
EP-1928979-B1 FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS ROLIC AG (CH) 2009-03-04 EP disclosed
US-20080274304-A1 Functionalized Photoreactive Compounds ROLIC AG (CH) 2008-11-06 US disclosed
EP-1764405-A1 Functionalized photoreactive compounds Rolic AG (CH) 2007-03-21 EP disclosed
CN-1100777-C N-heterocyclic derivatives as NOS inhibitor BERLEX LAB (US) 2003-02-05 CN disclosed
CN-1252799-A N-heterocyclic derivatives as NOS inhibitor BERLEX LAB (US) 2000-05-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274304-A1 Functionalized Photoreactive Compounds PCNA, PIN1, MAP1LC3C ALDH1A1 147/4885TSHR 4847/4885MAPT 1166/4885
US-20160083655-A1 CYANOSTILBENES LATS1, LATS2, CRY1 ALDH1A1 2838/4885TSHR 4718/4885MAPT 930/4885
US-10329486-B2 Cyanostilbenes LATS1, LATS2, CRY1 ALDH1A1 2838/4885TSHR 4718/4885MAPT 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.